IPO Summary: Strong Hands, Strong Start: Scribe Therapeutics Impresses on Debut
Strong Hands, Strong Start: Scribe Therapeutics Impresses on Debut Scribe Therapeutics (SCTX US) delivered one of the strongest biotechnology IPO debuts of the year, demonstrating that institutional investors remain willing to aggressively support differentiated life sciences companies despite a subdued IPO market. After upsizing the offering and pricing at the top of the range, shares surged[…]
